Skip to content

Business & MarketsBreaking

Eric Cantor Named President and CEO of Pharmaceutical Lobbying Group PhRMA

By

Coverage spectrum

Covered by 4 outlets, mostly right-leaning (75%).

4 articles in total. The spectrum counts each outlet once and leaves opinion out. How we measure bias

Former Republican House Majority Leader Eric Cantor has been named the next president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), the trade group announced Tuesday. Cantor will assume the role effective November 9. He represented Virginia’s 7th congressional district from 2000 to 2014 and served as House majority leader from 2011 to 2014 before losing a primary re-election bid. PhRMA Board of Directors Chair Rob Davis said Cantor is “well respected among policy leaders in Washington and around the world” and has “a long track record of working effectively across the political spectrum.” PhRMA describes itself as representing leading innovative biopharmaceutical research companies in the United States.

Headline and summary written by Mantle’s AI from the coverage below, under published rules. How this works

What happened

Key points

Each point shows who reports it, from Far Left to Far Right.

  1. Eric Cantor has been named the next president and CEO of PhRMA.

    Reported byCenterRight

  2. Cantor will assume the role effective November 9.

    Reported byRight

  3. Cantor served as a U.S. Representative from Virginia from 2000 to 2014 and as House Majority Leader from 2011 to 2014.

    Reported byRight

  4. Cantor lost re-election in what was widely described as a major upset.

    Reported byRight

  5. PhRMA Board Chair Rob Davis praised Cantor’s experience working across the political spectrum.

    Reported byRight

How each side tells it

Compare views

  • the left

    No coverage yet

    No left-leaning outlet that Mantle follows has covered this story yet. That absence is part of the picture.

  • the center

    1 outlet

    The Hill reports the appointment factually, focusing on the trade group's announcement without additional commentary.

    Eric Cantor named new president of pharma trade group
    The HillCenterAll center headlines

  • the right

    3 outlets

    Right-leaning outlets state the appointment as straightforward news, with Breitbart and the Daily Caller adding detail on Cantor’s congressional background and the Washington Times using more evaluative language calling the role ‘consequential.’

    Former House majority leader named CEO of major pharma lobbying group
    The Washington TimesRightAll right-leaning headlines

The words they chose

Language to notice

Words that carry a judgement beyond the facts. Tap a highlighted word anywhere on the page to see why.

  • Left

    Has not covered this story.

  • Center0

    No loaded words in its own voice.

  • Right1

    consequential lobbying job

In the outlets’ own words

  • Loaded modifier

    consequential lobbying jobMore neutral: a prominent lobbying position

    Characterizes the significance of the job in a way that goes beyond simple factual description.

    Former House Majority Leader Eric Cantor has been tapped for a consequential lobbying job: CEO of the Pharmaceutical Research and Manufacturers of America, also known…

    Used byThe Washington Times (Right)

See the full language guide

See for yourself

Side by side

What each side leads with and what it leaves out. Open a side to read its headlines.

From the left

0 outlets

No left-leaning outlet that Mantle follows has covered this story yet. That absence is part of the picture.

From the center

1 outlet

Leads with

  • PhRMA's role as a trade/lobbying organization
  • the announcement itself

Leaves out

  • Cantor's prior congressional record
  • details of PhRMA's statement praising Cantor

Reported by other sides, not found in this side’s coverage.

See the headline from the centerHide the headlines
  • The HillCenter

    Eric Cantor named new president of pharma trade group

    Click in for more news from The Hill {beacon} Healthcare Healthcare The Big Story Eric Cantor named new president of pharma trade group PhRMA, the leading lobbying and trade organization for the U.S. …

    Read at The Hill (opens in a new tab)

From the right

3 outlets

Leads with

  • Cantor's political history
  • PhRMA's statement praising him
  • details of the announcement
See the 3 headlines from the rightHide the headlines

Articles you open from here build My Mix, a private picture of how your reading spreads across the spectrum, kept on this device. What is My Mix?

The left is Far Left and Left together. The right is Right and Far Right together. Every outlet keeps its own five-point rating.

Who reported it when

How the coverage built up

  • Left

    No report yet

    From the outlets Mantle follows

  • Center

    6 hr later

    Its first report, Sep 29, 8:39 PM EDT

  • Right

    First to report

    The Daily Caller, Sep 29, 2:38 PM EDT

See the order the outlets reported inHide the order
  1. The Daily CallerFar RightSep 29, 2:38 PM EDT
  2. Breitbart NewsFar RightSep 29, 4:21 PM EDT
  3. The Washington TimesRightSep 29, 4:37 PM EDT
  4. The HillCenterSep 29, 8:39 PM EDT

Times are the ones the outlets published in their own feeds, in Eastern time. Opinion is left out.

Read next

Help someone else find the truth beneath the surface

Most people see one side of a story. Share this one, so they can see how every side is telling it and decide for themselves.

Email it

Seen a mistake? Tell us what is wrong with this page